Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 17alpha-ethynylestradiol | increases expression | ISO | Fbxo41 (Rattus norvegicus) | 6480464 | Ethinyl Estradiol results in increased expression of FBXO41 mRNA | CTD | PMID:29097150 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of FBXO41 mRNA | CTD | PMID:22574217 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of FBXO41 mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | decreases expression | ISO | Fbxo41 (Mus musculus) | 6480464 | bisphenol S results in decreased expression of FBXO41 mRNA | CTD | PMID:30951980 | 4,4'-sulfonyldiphenol | affects methylation | ISO | Fbxo41 (Mus musculus) | 6480464 | bisphenol S affects the methylation of FBXO41 gene | CTD | PMID:31683443 | 4,4'-sulfonyldiphenol | decreases methylation | ISO | Fbxo41 (Mus musculus) | 6480464 | bisphenol S results in decreased methylation of FBXO41 exon | CTD | PMID:33297965 | 5-aza-2'-deoxycytidine | decreases expression | EXP | | 6480464 | Decitabine results in decreased expression of FBXO41 mRNA | CTD | PMID:19194470 | aflatoxin B1 | increases methylation | EXP | | 6480464 | Aflatoxin B1 results in increased methylation of FBXO41 exon | CTD | PMID:30157460 | all-trans-retinoic acid | multiple interactions | ISO | Fbxo41 (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of FBXO41 mRNA | CTD | PMID:36189433 | antirheumatic drug | affects expression | EXP | | 6480464 | Antirheumatic Agents affects the expression of FBXO41 mRNA | CTD | PMID:24449571 | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of FBXO41 mRNA | CTD | PMID:33212167 | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of FBXO41 promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of FBXO41 3' UTR | CTD | PMID:27901495 | bisphenol A | decreases expression | ISO | Fbxo41 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of FBXO41 mRNA | CTD | PMID:25181051 and PMID:30816183 | bisphenol A | decreases expression | ISO | Fbxo41 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of FBXO41 mRNA | CTD | PMID:32156529 | bisphenol A | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of FBXO41 mRNA | CTD | PMID:28628672 | bisphenol A | increases expression | ISO | Fbxo41 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of FBXO41 mRNA | CTD | PMID:29097150 | chloroethene | increases expression | ISO | Fbxo41 (Mus musculus) | 6480464 | Vinyl Chloride results in increased expression of FBXO41 mRNA | CTD | PMID:18579281 | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of FBXO41 mRNA | CTD | PMID:27594783 | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of FBXO41 mRNA | CTD | PMID:25562108 | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of FBXO41 mRNA | CTD | PMID:28628672 | dicrotophos | increases expression | EXP | | 6480464 | dicrotophos results in increased expression of FBXO41 mRNA | CTD | PMID:28302478 | ethanol | affects splicing | ISO | Fbxo41 (Mus musculus) | 6480464 | Ethanol affects the splicing of FBXO41 mRNA | CTD | PMID:30319688 | genistein | decreases expression | ISO | Fbxo41 (Mus musculus) | 6480464 | Genistein results in decreased expression of FBXO41 mRNA | CTD | PMID:32186404 | gentamycin | decreases expression | ISO | Fbxo41 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of FBXO41 mRNA | CTD | PMID:33387578 | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of FBXO41 mRNA | CTD | PMID:28628672 | lead(0) | affects expression | EXP | | 6480464 | Lead affects the expression of FBXO41 mRNA | CTD | PMID:28903495 | maneb | multiple interactions | ISO | Fbxo41 (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in decreased expression of FBXO41 mRNA | CTD | PMID:36117858 | methotrexate | increases expression | EXP | | 6480464 | Methotrexate results in increased expression of FBXO41 mRNA | CTD | PMID:24449571 | methyl methanesulfonate | decreases expression | EXP | | 6480464 | Methyl Methanesulfonate results in decreased expression of FBXO41 mRNA | CTD | PMID:23649840 | mono(2-ethylhexyl) phthalate | multiple interactions | ISO | Fbxo41 (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of FBXO41 mRNA | CTD | PMID:36189433 | monosodium L-glutamate | increases expression | ISO | Fbxo41 (Mus musculus) | 6480464 | Sodium Glutamate results in increased expression of FBXO41 mRNA | CTD | PMID:22078008 | paracetamol | increases expression | ISO | Fbxo41 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of FBXO41 mRNA | CTD | PMID:33387578 | paraquat | multiple interactions | ISO | Fbxo41 (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in decreased expression of FBXO41 mRNA | CTD | PMID:36117858 | pentanal | increases expression | EXP | | 6480464 | pentanal results in increased expression of FBXO41 mRNA | CTD | PMID:26079696 | perfluorohexanesulfonic acid | decreases expression | EXP | | 6480464 | perfluorohexanesulfonic acid results in decreased expression of FBXO41 mRNA | CTD | PMID:25812627 | perfluorononanoic acid | decreases expression | EXP | | 6480464 | perfluoro-n-nonanoic acid results in decreased expression of FBXO41 mRNA | CTD | PMID:25812627 | perfluorooctane-1-sulfonic acid | decreases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in decreased expression of FBXO41 mRNA | CTD | PMID:25812627 | perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of FBXO41 mRNA | CTD | PMID:25812627 | phenethyl isothiocyanate | affects binding | EXP | | 6480464 | FBXO41 protein binds to phenethyl isothiocyanate | CTD | PMID:21838287 | propanal | increases expression | EXP | | 6480464 | propionaldehyde results in increased expression of FBXO41 mRNA | CTD | PMID:26079696 | quercetin | increases expression | EXP | | 6480464 | Quercetin results in increased expression of FBXO41 mRNA | CTD | PMID:21632981 | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of FBXO41 mRNA | CTD | PMID:31533062 | trichloroethene | increases expression | ISO | Fbxo41 (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased expression of FBXO41 mRNA | CTD | PMID:33387578 | urethane | decreases expression | EXP | | 6480464 | Urethane results in decreased expression of FBXO41 mRNA | CTD | PMID:28818685 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of FBXO41 mRNA | CTD | PMID:23179753 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of FBXO41 mRNA | CTD | PMID:25979313 | |